ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

243
Analysis
Health CareUnited States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
Refresh
11 Feb 2020 00:32

InnoCare Pharma IPO Initiation: Promising Prognosis

InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
382 Views
Share
03 Feb 2020 13:37

Akesobio (康方生物) Pre-IPO: Late in the PD-1 Game but Products Are Promising

Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...

Logo
591 Views
Share
bullishBNP Paribas
31 Jan 2020 17:25

They're Here: ESG Short Sellers

ESG short selling – i.e., shorting based on ESG metrics and catalysts – isn't new, but is undergoing a radical evolution. Short-term ESG trading...

Logo
538 Views
Share
bullishS&P 500 INDEX
12 Dec 2019 21:11

U. S. Equity Strategy: Small-Caps Closing the Gap

Major averages in the US (S&P 500, Dow, Russell 2000) and Europe (STOXX 600 & 50) each had throwbacks to their prior breakout levels last...

Logo
427 Views
Share
bearishKao Corp
28 Jun 2019 01:32

Merries Baby Diaper Business: Struggles to Continue Despite Company Remarks a Quick Turnaround

Kao is a well-known Japanese conglomerate involved in various business activities ranging from FMCG products to chemicals. The company operates in...

Logo
538 Views
Share
x